Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Category Archives: Financial Reports 2018

September 2018 Appendix 4C Quarterly Report and Company Update

Financial Reports 2018, News & Announcements 2018By PharmAustNovember 1, 2018

43zxgv0spl3ht0

PharmAust 2018 Annual Report

Financial Reports 2018, News & Announcements 2018By PharmAustOctober 1, 2018

181001_Annual_Report

Preliminary Final Statements to the ASX

Financial Reports 2018, News & Announcements 2018By PharmAustSeptember 3, 2018

180903_Preliminary Final Report

Top 20 Shareholders August 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustAugust 17, 2018

Top 20 Shareholders August 2018

Top 20 Shareholders July 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustJuly 13, 2018

Top_Holders_Report (4)

Top 20 Shareholders June 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustJune 10, 2018

Top 20 04.06.18

PharmAust Appendix 4C and Shareholders Update (Q3, 2018 FY)

Financial Reports 2018, News & Announcements 2018By PharmAustMay 1, 2018

180501_4C and Shareholders Update_March

Top 20 Shareholders April 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustApril 27, 2018

Top 20 Share Holders April 2018

SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001

Financial Reports 2018, News & Announcements 2018By PharmAustMarch 20, 2018

180320_Cleansing Notice

Appendix 3B: New issue announcement, application for quotation of additional securities and agreement

Financial Reports 2018, News & Announcements 2018By PharmAustMarch 16, 2018

180316_Appendix 3B and 3Y Notice

12
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on Twitter PharmAust Retweeted
pharmaust PharmAust @pharmaust ·
25 Jul

PharmAust is pleased to announce that leading Australian broking and corporate advisory firm, @JPEquityPartner, has updated their research coverage on $PAA
 
A full copy of the research note is available for download here 👉 https://www.pharmaust.com/jp-equity-research-report/

Reply on Twitter 1551424206805405699 Retweet on Twitter 1551424206805405699 3 Like on Twitter 1551424206805405699 13 Twitter 1551424206805405699
Load More
Copyright © 2020 Pharmaust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top